Ensuring quality care for breast cancer patients globally
Ensuring quality care for breast cancer patients globally
Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma
E2108: Systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer
KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-stage small-cell lung cancer
Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer
The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy in advanced urothelial carcinoma
Better genetic diagnostics in Ugandan breast cancer patients
Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer
Update from KAITLIN for high-risk HER2-positive early breast cancer
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma
Sym015 shows superior specificity compared to TKIs for NSCLC